Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Psychiatric clearance for patients started on interferon-alpha-based therapies.

Lotrich FE.

Am J Psychiatry. 2013 Jun;170(6):592-7. doi: 10.1176/appi.ajp.2013.12121572. No abstract available.

2.

Psychiatric treatment considerations with direct acting antivirals in hepatitis C.

Sockalingam S, Tseng A, Giguere P, Wong D.

BMC Gastroenterol. 2013 May 14;13:86. doi: 10.1186/1471-230X-13-86. Review.

3.

Completion of chronic hepatitis C virus treatment in interferon-induced major depressive disorder with psychotic features.

Park SH.

Psychiatry Investig. 2011 Dec;8(4):381-3. doi: 10.4306/pi.2011.8.4.381. Epub 2011 Nov 14.

4.
5.

Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices.

Weiss JJ, Morgello S.

Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):531-7. doi: 10.1016/j.genhosppsych.2009.05.006. Epub 2009 Jun 9.

6.

Interferon-alpha causes neuronal dysfunction in encephalitis.

Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR.

J Neurosci. 2009 Mar 25;29(12):3948-55. doi: 10.1523/JNEUROSCI.5595-08.2009.

7.

Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.

Weiss JJ, Gorman JM.

Curr HIV/AIDS Rep. 2006 Nov;3(4):176-81. Review.

8.

Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

Raison CL, Demetrashvili M, Capuron L, Miller AH.

CNS Drugs. 2005;19(2):105-23. Review.

Supplemental Content

Support Center